Assistance Publique des Hôpitaux de Paris SA
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1849-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.aphp.fr
"Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 60
- Registration Number
- NCT05874505
Prosody Assessment After Right Hemisphere Stroke
Not yet recruiting
- Conditions
- Right Hemisphere Stroke
- Interventions
- Other: understanding of prosody
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 150
- Registration Number
- NCT05874011
Assessment of Bronchial Obstruction in Adolescents With HIV
Not Applicable
Completed
- Conditions
- HIV
- Interventions
- Diagnostic Test: pulmonary function tests
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 21
- Registration Number
- NCT05869084
- Locations
- 🇫🇷
Robert Debre Hospital, Paris, France
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
Recruiting
- Conditions
- CoagulationChronic Liver Diseases
- Interventions
- Other: biomarker assay
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 360
- Registration Number
- NCT05865691
- Locations
- 🇫🇷
Beaujon Hospital, Clichy, France
Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psychiatric Disorders
Recruiting
- Conditions
- Major Depressive Episode
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 1000
- Registration Number
- NCT05866991
- Locations
- 🇫🇷
Hôpital Bichat Claude Bernard, Paris, France
Better Classification of Respiratory Amyloidosis
Not yet recruiting
- Conditions
- Amyloidosis
- First Posted Date
- 2023-05-17
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 70
- Registration Number
- NCT05862961
Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients
Phase 2
Not yet recruiting
- Conditions
- Walking CapacityAmyotrophic Lateral Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 36
- Registration Number
- NCT05860244
- Locations
- 🇫🇷
Hôpital Pitié Salpêtrière, Paris, France
Cannabidiol As an Add-on Treatment During Inpatient Alcohol Cessation : CBD-OH
Phase 2
Recruiting
- Conditions
- Severe Alcohol Use Disorder (DSM 5)
- Interventions
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 210
- Registration Number
- NCT05860699
- Locations
- 🇫🇷
Hôpital Fernand Widal, Paris, France
Colchicine Versus Placebo in Acute Myocarditis Patients
- First Posted Date
- 2023-05-11
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 300
- Registration Number
- NCT05855746
- Locations
- 🇫🇷
Unité de Soins Intensifs Cardiologiques - Hôpital Cardiovasculaire Louis Pradel, Bron, France
🇫🇷Institut de Cardiologie - APHP Pitié Salpêtrière, Paris, France
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Phase 3
Recruiting
- Conditions
- Pulmonary HypertensionChronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 200
- Registration Number
- NCT05844462
- Locations
- 🇫🇷
Kremlin Bicêtre, Kremlin Bicêtre, France
© Copyright 2025. All Rights Reserved by MedPath